Covered recipient · General Payments record
THOMAS ALEXANDER HARRISON
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2020–2024
$1,374.68
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $493.33 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Kerecis Limited | $144.88 | 2 |
| E.R. Squibb & Sons, L.L.C. | $122.13 | 1 |
| ORGANOGENESIS INC. | $62.06 | 2 |
| Amgen Inc. | $42.89 | 2 |
| ABBVIE INC. | $38.09 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.09 | 1 |
| Smith & Nephew, Inc. | $26.76 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.16 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103885391 | CMS |
| ABBVIE INC. | $19.93 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103885393 | CMS |
| Amgen Inc. | $15.30 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117573916 | CMS |
| Amgen Inc. | $27.59 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117573918 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.43 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117974359 | CMS |
| E.R. Squibb & Sons, L.L.C. | $122.13 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101818241 | CMS |
| Kerecis Limited | $19.24 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120099600 | CMS |
| Kerecis Limited | $125.64 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120119846 | CMS |
| Novartis Pharmaceuticals Corporation | $34.09 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086959703 | CMS |
| Organogenesis Inc. | $34.27 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145430625 | CMS |
| Organogenesis Inc. | $27.79 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145430627 | CMS |
| Smith+Nephew, Inc. | $26.76 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149598514 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.